akiron® NEO

akiron® NEO

AI-driven Diagnostics

Information

The akiron® NEO is a compact benchtop IFA analyzer for automated digital imaging of processed immunofluorescence slides to support the diagnosis of autoimmune diseases. The akiron® NEO software based on artificial intelligence (AI) allows for an objective ANA / ANCA pattern recognition and intensity evaluation in about 35 seconds.* Validated akiron® NEO assay files support the standardized evaluation of a variety of immunofluorescence assays, ranging from determination of antibodies against HEp-2 cells (ANA), granulocytes (ANCA), CLIFT (dsDNA), several tissues as well as against specific antigens using the CytoBead® technology. The powerful, easy-to-use akiron® NEO with a small footprint is indispensable for all routine diagnostic services, e.g. in rheumatology and gastroenterology, and not only for laboratories with limited bench space. * ANA / ANCA / CLIFT
Medipan & GA Generic AssaysH4.E18Medipan GmbH is a German family-owned company with over 30 years of experience in innovative diagnostic solutions for autoimmune diseases. Based in Dahlewitz near Berlin, Medipan offers high-quality manual assays and advanced automated systems for laboratory diagnostics. The portfolio includes solutions for ELISA, immunofluorescence, lateral flow, LINE & Dot assays, covering a broad range of autoimmune and related diseases. A strong focus lies on digital diagnostics, including the akiron® NEO, a compact fully automated IFA analyzer supporting standardized imaging and evaluation. Together with its sister company GA Generic Assays GmbH, Medipan operates in more than 70 countries, providing reliable and innovative diagnostic solutions for laboratories worldwide.

Log in

See all the content and easy-to-use features by logging in or registering!